An evaluation of the in vivo properties of 99mTc-HEDP.
The in vitro properties of lyophilized 99mTc stannous diphosphonate bone-scanning agent have been studied with particular reference to those properties which are of relevance to its routine clinical use. The results of quantitative studies in patients with bony tumors indicate that reliable reproducible bone scans will be obtained despite the variations in technetium presentation, labelling and injection procedures which may be anticipated in any department of nuclear medicine.